BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8821696)

  • 21. VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.
    Dirim A; Haberal AN; Goren MR; Tekin MI; Peskircioglu L; Demirhan B; Ozkardes H
    Int Urol Nephrol; 2008; 40(4):861-8. PubMed ID: 18324478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
    Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between the production of interleukin-6 and the proliferating cell nuclear antigen (PCNA) expression in renal cell carcinoma].
    Ikeda R; Moriyama M; Nakade T; Tsugawa R; Suzuki K
    Hinyokika Kiyo; 1998 Apr; 44(4):233-8. PubMed ID: 9617618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms tumors: relationship of nuclear deoxyribonucleic acid ploidy to patient survival.
    Rainwater LM; Hosaka Y; Farrow GM; Kramer SA; Kelalis PP; Lieber MM
    J Urol; 1987 Oct; 138(4 Pt 2):974-7. PubMed ID: 2821294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
    El-kott AF; El-baz MA; Mokhtar AA
    Int Urol Nephrol; 2006; 38(2):237-42. PubMed ID: 16868689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases.
    Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF
    Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I; Une Y; Uchino J
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers.
    Lopes JM; Hannisdal E; Bjerkehagen B; Bruland OS; Danielsen HE; Pettersen EO; Sobrinho-Simões M; Nesland JM
    Anal Cell Pathol; 1998; 16(1):45-62. PubMed ID: 9584899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients.
    Danesi DT; Spanò M; Fabiano A; Altavista P; Pasqualetti P; Toscano MG; Antonini F; Catalano P; Mecozzi A; Picconi A; Daffinà A; Cucchiara G
    Cytometry; 2000 Feb; 42(1):27-34. PubMed ID: 10679740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
    Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
    Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
    Choi HJ; Jung IK; Kim SS; Hong SH
    Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
    Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
    Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma.
    Kamel D; Turpeenniemi-Hujanen T; Vähäkangas K; Pääkkö P; Soini Y
    Histopathology; 1994 Oct; 25(4):339-47. PubMed ID: 7835839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
    Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
    Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.